Dr. Saseen is an Associate Professor of Clinical Pharmacy and Family Medicine at the University of Colorado Denver. He is a Board Certified Pharmacotherapy Specialist with added qualifications in cardiology, is certified as a Clinical Lipid Specialist, and is a Fellow of the American College of Clinical Pharmacy. Dr. Saseen received both his B.S. pharmacy degree and PharmD degree from the State University of New York at Buffalo and then completed an ambulatory care research fellowship at the University of Illinois at Chicago. In his current position, Dr. Saseen practices as a clinical pharmacy specialist at University of Colorado’s Family Medicine Center, and educates pharmacy and medical students. His research and other scholarly endeavors focus on cardiovascular pharmacotherapy. Dr. Saseen is on the board of regents for the American College of Clinical Pharmacy, is a member of the Board of Directors for the National Lipid Association’s Accreditation Council for Clinical Lipidology, and is a member of the Board of Directors and Editorial Board for the journal Pharmacotherapy. He has won several teaching awards, most recently was the recipient of the Doctor of Pharmacy Class of 2009’s Outstanding Instructor Award in May of 2008.
Description
Learning Objectives: Review evidence-based pharmacotherapy recommendations provided in the JNC 7. Discuss findings from The Blood Pressure Lowering Treatment Trialists? Collaboration?s most recent meta-analysis. Compare and contrast recent evidence from ALLHAT and ASCOT trials and debate how these results should influence first line antihypertensive therapy. Evaluate recent evidence that demonstrates beta-blocker therapy for hypertension does not reduce cardiovascular events.